Gene symbol: Pik3ca

Organism: Rattus norvegicus

Summary: Enables 1-phosphatidylinositol-3-kinase activity. Involved in several processes, including positive regulation of smooth muscle cell proliferation; response to dexamethasone; and response to leucine. Part of phosphatidylinositol 3-kinase complex. Biomarker of autosomal recessive polycystic kidney disease. Human ortholog(s) of this gene implicated in several diseases, including CLOVES syndrome; Cowden syndrome 5; breast cancer (multiple); cutaneous Paget's disease; and gastrointestinal system cancer (multiple). Orthologous to human PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha). [provided by Alliance of Genome Resources, Apr 2022]

NCBI gene ID: 170911 EnsemblRapid:ENSRNOG00000056371 AllianceGenome:RGD:620916


GO Annotation


Category Term ID Term description
Process GO:0001101 Response to acid chemical
Process GO:0001525 Angiogenesis
Process GO:0001568 Blood vessel development
Process GO:0001678 Cellular glucose homeostasis
Process GO:0001889 Liver development
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001944 Vasculature development
Process GO:0003008 System process
Process GO:0003012 Muscle system process
Process GO:0003013 Circulatory system process
Process GO:0003015 Heart process
Process GO:0005975 Carbohydrate metabolic process
Process GO:0005996 Monosaccharide metabolic process
Process GO:0006006 Glucose metabolic process
Process GO:0006629 Lipid metabolic process
Process GO:0006644 Phospholipid metabolic process
Process GO:0006650 Glycerophospholipid metabolic process
Process GO:0006661 Phosphatidylinositol biosynthetic process
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006810 Transport
Process GO:0006909 Phagocytosis
Process GO:0006936 Muscle contraction
Process GO:0006941 Striated muscle contraction
Process GO:0006950 Response to stress
Process GO:0006996 Organelle organization
Process GO:0007010 Cytoskeleton organization
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007167 Enzyme-linked receptor protein signaling pathway
Process GO:0007169 Transmembrane receptor protein tyrosine kinase signaling pathway
Process GO:0007275 Multicellular organism development
Process GO:0008015 Blood circulation
Process GO:0008064 Regulation of actin polymerization or depolymerization
Process GO:0008152 Metabolic process
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008610 Lipid biosynthetic process
Process GO:0008654 Phospholipid biosynthetic process
Process GO:0009058 Biosynthetic process
Process GO:0009415 Response to water
Process GO:0009605 Response to external stimulus
Process GO:0009612 Response to mechanical stimulus
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009743 Response to carbohydrate
Process GO:0009746 Response to hexose
Process GO:0009749 Response to glucose
Process GO:0009888 Tissue development
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010468 Regulation of gene expression
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010629 Negative regulation of gene expression
Process GO:0010639 Negative regulation of organelle organization
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010847 Regulation of chromatin assembly
Process GO:0010941 Regulation of cell death
Process GO:0014065 Phosphatidylinositol 3-kinase signaling
Process GO:0014070 Response to organic cyclic compound
Process GO:0014823 Response to activity
Process GO:0014854 Response to inactivity
Process GO:0014870 Response to muscle inactivity
Process GO:0016043 Cellular component organization
Process GO:0016192 Vesicle-mediated transport
Process GO:0016310 Phosphorylation
Process GO:0016477 Cell migration
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019318 Hexose metabolic process
Process GO:0019637 Organophosphate metabolic process
Process GO:0019725 Cellular homeostasis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0030029 Actin filament-based process
Process GO:0030036 Actin cytoskeleton organization
Process GO:0030048 Actin filament-based movement
Process GO:0030832 Regulation of actin filament length
Process GO:0030834 Regulation of actin filament depolymerization
Process GO:0030835 Negative regulation of actin filament depolymerization
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031399 Regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031445 Regulation of heterochromatin assembly
Process GO:0031960 Response to corticosteroid
Process GO:0032147 Activation of protein kinase activity
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032535 Regulation of cellular component size
Process GO:0032956 Regulation of actin cytoskeleton organization
Process GO:0032970 Regulation of actin filament-based process
Process GO:0033043 Regulation of organelle organization
Process GO:0033135 Regulation of peptidyl-serine phosphorylation
Process GO:0033138 Positive regulation of peptidyl-serine phosphorylation
Process GO:0033500 Carbohydrate homeostasis
Process GO:0033554 Cellular response to stress
Process GO:0033674 Positive regulation of kinase activity
Process GO:0033993 Response to lipid
Process GO:0034284 Response to monosaccharide
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0035556 Intracellular signal transduction
Process GO:0035924 Cellular response to vascular endothelial growth factor stimulus
Process GO:0035994 Response to muscle stretch
Process GO:0036092 phosphatidylinositol-3-phosphate biosynthetic process
Process GO:0038084 Vascular endothelial growth factor signaling pathway
Process GO:0040008 Regulation of growth
Process GO:0040014 Regulation of multicellular organism growth
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042592 Homeostatic process
Process GO:0042593 Glucose homeostasis
Process GO:0042981 Regulation of apoptotic process
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043200 Response to amino acid
Process GO:0043201 Response to leucine
Process GO:0043242 Negative regulation of protein-containing complex disassembly
Process GO:0043244 Regulation of protein-containing complex disassembly
Process GO:0043457 Regulation of cellular respiration
Process GO:0043467 Regulation of generation of precursor metabolites and energy
Process GO:0043491 Protein kinase B signaling
Process GO:0043523 Regulation of neuron apoptotic process
Process GO:0043524 Negative regulation of neuron apoptotic process
Process GO:0043549 Regulation of kinase activity
Process GO:0044028 DNA hypomethylation
Process GO:0044029 Hypomethylation of CpG island
Process GO:0044030 Regulation of DNA methylation
Process GO:0044087 Regulation of cellular component biogenesis
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044255 Cellular lipid metabolic process
Process GO:0044281 Small molecule metabolic process
Process GO:0045017 Glycerolipid biosynthetic process
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0046474 Glycerophospholipid biosynthetic process
Process GO:0046486 Glycerolipid metabolic process
Process GO:0046488 Phosphatidylinositol metabolic process
Process GO:0046854 Phosphatidylinositol phosphate biosynthetic process
Process GO:0048015 Phosphatidylinositol-mediated signaling
Process GO:0048017 Inositol lipid-mediated signaling
Process GO:0048513 Animal organ development
Process GO:0048514 Blood vessel morphogenesis
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048545 Response to steroid hormone
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048638 Regulation of developmental growth
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048660 Regulation of smooth muscle cell proliferation
Process GO:0048661 Positive regulation of smooth muscle cell proliferation
Process GO:0048731 System development
Process GO:0048732 Gland development
Process GO:0048856 Anatomical structure development
Process GO:0048870 Cell motility
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0048878 Chemical homeostasis
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050896 Response to stimulus
Process GO:0051052 Regulation of DNA metabolic process
Process GO:0051128 Regulation of cellular component organization
Process GO:0051129 Negative regulation of cellular component organization
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051338 Regulation of transferase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051384 Response to glucocorticoid
Process GO:0051493 Regulation of cytoskeleton organization
Process GO:0051494 Negative regulation of cytoskeleton organization
Process GO:0051599 Response to hydrostatic pressure
Process GO:0051716 Cellular response to stimulus
Process GO:0051896 Regulation of protein kinase B signaling
Process GO:0051897 Positive regulation of protein kinase B signaling
Process GO:0055082 Cellular chemical homeostasis
Process GO:0055119 Relaxation of cardiac muscle
Process GO:0060047 Heart contraction
Process GO:0060048 Cardiac muscle contraction
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060548 Negative regulation of cell death
Process GO:0060612 Adipose tissue development
Process GO:0061008 Hepaticobiliary system development
Process GO:0061448 Connective tissue development
Process GO:0062197 Cellular response to chemical stress
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070252 Actin-mediated cell contraction
Process GO:0070542 Response to fatty acid
Process GO:0070848 Response to growth factor
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071214 Cellular response to abiotic stimulus
Process GO:0071229 Cellular response to acid chemical
Process GO:0071310 Cellular response to organic substance
Process GO:0071322 Cellular response to carbohydrate stimulus
Process GO:0071326 Cellular response to monosaccharide stimulus
Process GO:0071331 Cellular response to hexose stimulus
Process GO:0071333 Cellular response to glucose stimulus
Process GO:0071363 Cellular response to growth factor stimulus
Process GO:0071462 Cellular response to water stimulus
Process GO:0071464 Cellular response to hydrostatic pressure
Process GO:0071548 Response to dexamethasone
Process GO:0071704 Organic substance metabolic process
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0072359 Circulatory system development
Process GO:0080090 Regulation of primary metabolic process
Process GO:0086003 Cardiac muscle cell contraction
Process GO:0090066 Regulation of anatomical structure size
Process GO:0090075 Relaxation of muscle
Process GO:0090407 Organophosphate biosynthetic process
Process GO:0097009 Energy homeostasis
Process GO:0104004 Cellular response to environmental stimulus
Process GO:0110053 Regulation of actin filament organization
Process GO:0120261 Regulation of heterochromatin organization
Process GO:1901214 Regulation of neuron death
Process GO:1901215 Negative regulation of neuron death
Process GO:1901576 Organic substance biosynthetic process
Process GO:1901654 Response to ketone
Process GO:1901698 Response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1901879 Regulation of protein depolymerization
Process GO:1901880 Negative regulation of protein depolymerization
Process GO:1902275 Regulation of chromatin organization
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902903 Regulation of supramolecular fiber organization
Process GO:1902904 Negative regulation of supramolecular fiber organization
Process GO:1903544 Response to butyrate
Process GO:2000209 Regulation of anoikis
Process GO:2000269 Regulation of fibroblast apoptotic process
Process GO:2000270 Negative regulation of fibroblast apoptotic process
Process GO:2000653 Regulation of genetic imprinting
Process GO:2000811 Negative regulation of anoikis
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005829 Cytosol
Component GO:0005886 Plasma membrane
Component GO:0005911 Cell-cell junction
Component GO:0005942 Phosphatidylinositol 3-kinase complex
Component GO:0005943 Phosphatidylinositol 3-kinase complex, class IA
Component GO:0005944 Phosphatidylinositol 3-kinase complex, class IB
Component GO:0014704 Intercalated disc
Component GO:0016020 Membrane
Component GO:0019898 Extrinsic component of membrane
Component GO:0030027 Lamellipodium
Component GO:0030054 Cell junction
Component GO:0031252 Cell leading edge
Component GO:0032991 Protein-containing complex
Component GO:0042995 Cell projection
Component GO:0044291 Cell-cell contact zone
Component GO:0061695 Transferase complex, transferring phosphorus-containing groups
Component GO:0070161 Anchoring junction
Component GO:0071944 Cell periphery
Component GO:0097651 Phosphatidylinositol 3-kinase complex, class I
Component GO:0098796 Membrane protein complex
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:1902494 Catalytic complex
Component GO:1990234 Transferase complex
Function GO:0000166 Nucleotide binding
Function GO:0003824 Catalytic activity
Function GO:0004672 Protein kinase activity
Function GO:0004674 Protein serine/threonine kinase activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0005524 ATP binding
Function GO:0008047 Enzyme activator activity
Function GO:0016301 Kinase activity
Function GO:0016303 1-phosphatidylinositol-3-kinase activity
Function GO:0016307 Phosphatidylinositol phosphate kinase activity
Function GO:0016740 Transferase activity
Function GO:0016772 Transferase activity, transferring phosphorus-containing groups
Function GO:0016773 Phosphotransferase activity, alcohol group as acceptor
Function GO:0017076 Purine nucleotide binding
Function GO:0019207 Kinase regulator activity
Function GO:0019209 Kinase activator activity
Function GO:0019887 Protein kinase regulator activity
Function GO:0030234 Enzyme regulator activity
Function GO:0030295 Protein kinase activator activity
Function GO:0030554 Adenyl nucleotide binding
Function GO:0032553 Ribonucleotide binding
Function GO:0032555 Purine ribonucleotide binding
Function GO:0032559 Adenyl ribonucleotide binding
Function GO:0035004 Phosphatidylinositol 3-kinase activity
Function GO:0035005 1-phosphatidylinositol-4-phosphate 3-kinase activity
Function GO:0035639 Purine ribonucleoside triphosphate binding
Function GO:0036094 Small molecule binding
Function GO:0043167 Ion binding
Function GO:0043168 Anion binding
Function GO:0043560 Insulin receptor substrate binding
Function GO:0046934 phosphatidylinositol-4,5-bisphosphate 3-kinase activity
Function GO:0052742 Phosphatidylinositol kinase activity
Function GO:0052812 phosphatidylinositol-3,4-bisphosphate 5-kinase activity
Function GO:0052813 Phosphatidylinositol bisphosphate kinase activity
Function GO:0097159 Organic cyclic compound binding
Function GO:0097367 Carbohydrate derivative binding
Function GO:0098772 Molecular function regulator activity
Function GO:0106310 Protein serine kinase activity
Function GO:0140096 Catalytic activity, acting on a protein
Function GO:1901265 Nucleoside phosphate binding
Function GO:1901363 Heterocyclic compound binding
Process GO:0001101 Response to acid chemical
Process GO:0001525 Angiogenesis
Process GO:0001568 Blood vessel development
Process GO:0001678 Cellular glucose homeostasis
Process GO:0001889 Liver development
Process GO:0001932 Regulation of protein phosphorylation
Process GO:0001934 Positive regulation of protein phosphorylation
Process GO:0001944 Vasculature development
Process GO:0003008 System process
Process GO:0003012 Muscle system process
Process GO:0003013 Circulatory system process
Process GO:0003015 Heart process
Process GO:0005975 Carbohydrate metabolic process
Process GO:0005996 Monosaccharide metabolic process
Process GO:0006006 Glucose metabolic process
Process GO:0006629 Lipid metabolic process
Process GO:0006644 Phospholipid metabolic process
Process GO:0006650 Glycerophospholipid metabolic process
Process GO:0006661 Phosphatidylinositol biosynthetic process
Process GO:0006793 Phosphorus metabolic process
Process GO:0006796 Phosphate-containing compound metabolic process
Process GO:0006810 Transport
Process GO:0006909 Phagocytosis
Process GO:0006936 Muscle contraction
Process GO:0006941 Striated muscle contraction
Process GO:0006950 Response to stress
Process GO:0006996 Organelle organization
Process GO:0007010 Cytoskeleton organization
Process GO:0007154 Cell communication
Process GO:0007165 Signal transduction
Process GO:0007166 Cell surface receptor signaling pathway
Process GO:0007167 Enzyme-linked receptor protein signaling pathway
Process GO:0007169 Transmembrane receptor protein tyrosine kinase signaling pathway
Process GO:0007275 Multicellular organism development
Process GO:0008015 Blood circulation
Process GO:0008064 Regulation of actin polymerization or depolymerization
Process GO:0008152 Metabolic process
Process GO:0008284 Positive regulation of cell population proliferation
Process GO:0008610 Lipid biosynthetic process
Process GO:0008654 Phospholipid biosynthetic process
Process GO:0009058 Biosynthetic process
Process GO:0009415 Response to water
Process GO:0009605 Response to external stimulus
Process GO:0009612 Response to mechanical stimulus
Process GO:0009628 Response to abiotic stimulus
Process GO:0009653 Anatomical structure morphogenesis
Process GO:0009719 Response to endogenous stimulus
Process GO:0009725 Response to hormone
Process GO:0009743 Response to carbohydrate
Process GO:0009746 Response to hexose
Process GO:0009749 Response to glucose
Process GO:0009888 Tissue development
Process GO:0009892 Negative regulation of metabolic process
Process GO:0009893 Positive regulation of metabolic process
Process GO:0009966 Regulation of signal transduction
Process GO:0009967 Positive regulation of signal transduction
Process GO:0009987 Cellular process
Process GO:0010033 Response to organic substance
Process GO:0010035 Response to inorganic substance
Process GO:0010243 Response to organonitrogen compound
Process GO:0010468 Regulation of gene expression
Process GO:0010562 Positive regulation of phosphorus metabolic process
Process GO:0010604 Positive regulation of macromolecule metabolic process
Process GO:0010605 Negative regulation of macromolecule metabolic process
Process GO:0010629 Negative regulation of gene expression
Process GO:0010639 Negative regulation of organelle organization
Process GO:0010646 Regulation of cell communication
Process GO:0010647 Positive regulation of cell communication
Process GO:0010847 Regulation of chromatin assembly
Process GO:0010941 Regulation of cell death
Process GO:0014065 Phosphatidylinositol 3-kinase signaling
Process GO:0014070 Response to organic cyclic compound
Process GO:0014823 Response to activity
Process GO:0014854 Response to inactivity
Process GO:0014870 Response to muscle inactivity
Process GO:0016043 Cellular component organization
Process GO:0016192 Vesicle-mediated transport
Process GO:0016310 Phosphorylation
Process GO:0016477 Cell migration
Process GO:0019219 Regulation of nucleobase-containing compound metabolic process
Process GO:0019220 Regulation of phosphate metabolic process
Process GO:0019222 Regulation of metabolic process
Process GO:0019318 Hexose metabolic process
Process GO:0019637 Organophosphate metabolic process
Process GO:0019725 Cellular homeostasis
Process GO:0023051 Regulation of signaling
Process GO:0023052 Signaling
Process GO:0023056 Positive regulation of signaling
Process GO:0030029 Actin filament-based process
Process GO:0030036 Actin cytoskeleton organization
Process GO:0030048 Actin filament-based movement
Process GO:0030832 Regulation of actin filament length
Process GO:0030834 Regulation of actin filament depolymerization
Process GO:0030835 Negative regulation of actin filament depolymerization
Process GO:0031323 Regulation of cellular metabolic process
Process GO:0031325 Positive regulation of cellular metabolic process
Process GO:0031399 Regulation of protein modification process
Process GO:0031401 Positive regulation of protein modification process
Process GO:0031445 Regulation of heterochromatin assembly
Process GO:0031960 Response to corticosteroid
Process GO:0032147 Activation of protein kinase activity
Process GO:0032501 Multicellular organismal process
Process GO:0032502 Developmental process
Process GO:0032535 Regulation of cellular component size
Process GO:0032956 Regulation of actin cytoskeleton organization
Process GO:0032970 Regulation of actin filament-based process
Process GO:0033043 Regulation of organelle organization
Process GO:0033135 Regulation of peptidyl-serine phosphorylation
Process GO:0033138 Positive regulation of peptidyl-serine phosphorylation
Process GO:0033500 Carbohydrate homeostasis
Process GO:0033554 Cellular response to stress
Process GO:0033674 Positive regulation of kinase activity
Process GO:0033993 Response to lipid
Process GO:0034284 Response to monosaccharide
Process GO:0035239 Tube morphogenesis
Process GO:0035295 Tube development
Process GO:0035556 Intracellular signal transduction
Process GO:0035924 Cellular response to vascular endothelial growth factor stimulus
Process GO:0035994 Response to muscle stretch
Process GO:0036092 phosphatidylinositol-3-phosphate biosynthetic process
Process GO:0038084 Vascular endothelial growth factor signaling pathway
Process GO:0040008 Regulation of growth
Process GO:0040014 Regulation of multicellular organism growth
Process GO:0042127 Regulation of cell population proliferation
Process GO:0042221 Response to chemical
Process GO:0042325 Regulation of phosphorylation
Process GO:0042327 Positive regulation of phosphorylation
Process GO:0042592 Homeostatic process
Process GO:0042593 Glucose homeostasis
Process GO:0042981 Regulation of apoptotic process
Process GO:0043066 Negative regulation of apoptotic process
Process GO:0043067 Regulation of programmed cell death
Process GO:0043069 Negative regulation of programmed cell death
Process GO:0043085 Positive regulation of catalytic activity
Process GO:0043200 Response to amino acid
Process GO:0043201 Response to leucine
Process GO:0043242 Negative regulation of protein-containing complex disassembly
Process GO:0043244 Regulation of protein-containing complex disassembly
Process GO:0043457 Regulation of cellular respiration
Process GO:0043467 Regulation of generation of precursor metabolites and energy
Process GO:0043491 Protein kinase B signaling
Process GO:0043523 Regulation of neuron apoptotic process
Process GO:0043524 Negative regulation of neuron apoptotic process
Process GO:0043549 Regulation of kinase activity
Process GO:0044028 DNA hypomethylation
Process GO:0044029 Hypomethylation of CpG island
Process GO:0044030 Regulation of DNA methylation
Process GO:0044087 Regulation of cellular component biogenesis
Process GO:0044093 Positive regulation of molecular function
Process GO:0044237 Cellular metabolic process
Process GO:0044238 Primary metabolic process
Process GO:0044249 Cellular biosynthetic process
Process GO:0044255 Cellular lipid metabolic process
Process GO:0044281 Small molecule metabolic process
Process GO:0045017 Glycerolipid biosynthetic process
Process GO:0045859 Regulation of protein kinase activity
Process GO:0045860 Positive regulation of protein kinase activity
Process GO:0045937 Positive regulation of phosphate metabolic process
Process GO:0046474 Glycerophospholipid biosynthetic process
Process GO:0046486 Glycerolipid metabolic process
Process GO:0046488 Phosphatidylinositol metabolic process
Process GO:0046854 Phosphatidylinositol phosphate biosynthetic process
Process GO:0048015 Phosphatidylinositol-mediated signaling
Process GO:0048017 Inositol lipid-mediated signaling
Process GO:0048513 Animal organ development
Process GO:0048514 Blood vessel morphogenesis
Process GO:0048518 Positive regulation of biological process
Process GO:0048519 Negative regulation of biological process
Process GO:0048522 Positive regulation of cellular process
Process GO:0048523 Negative regulation of cellular process
Process GO:0048545 Response to steroid hormone
Process GO:0048583 Regulation of response to stimulus
Process GO:0048584 Positive regulation of response to stimulus
Process GO:0048638 Regulation of developmental growth
Process GO:0048646 Anatomical structure formation involved in morphogenesis
Process GO:0048660 Regulation of smooth muscle cell proliferation
Process GO:0048661 Positive regulation of smooth muscle cell proliferation
Process GO:0048731 System development
Process GO:0048732 Gland development
Process GO:0048856 Anatomical structure development
Process GO:0048870 Cell motility
Process GO:0048871 Multicellular organismal homeostasis
Process GO:0048878 Chemical homeostasis
Process GO:0050789 Regulation of biological process
Process GO:0050790 Regulation of catalytic activity
Process GO:0050793 Regulation of developmental process
Process GO:0050794 Regulation of cellular process
Process GO:0050896 Response to stimulus
Process GO:0051052 Regulation of DNA metabolic process
Process GO:0051128 Regulation of cellular component organization
Process GO:0051129 Negative regulation of cellular component organization
Process GO:0051171 Regulation of nitrogen compound metabolic process
Process GO:0051173 Positive regulation of nitrogen compound metabolic process
Process GO:0051174 Regulation of phosphorus metabolic process
Process GO:0051179 Localization
Process GO:0051234 Establishment of localization
Process GO:0051239 Regulation of multicellular organismal process
Process GO:0051246 Regulation of protein metabolic process
Process GO:0051247 Positive regulation of protein metabolic process
Process GO:0051338 Regulation of transferase activity
Process GO:0051347 Positive regulation of transferase activity
Process GO:0051384 Response to glucocorticoid
Process GO:0051493 Regulation of cytoskeleton organization
Process GO:0051494 Negative regulation of cytoskeleton organization
Process GO:0051599 Response to hydrostatic pressure
Process GO:0051716 Cellular response to stimulus
Process GO:0051896 Regulation of protein kinase B signaling
Process GO:0051897 Positive regulation of protein kinase B signaling
Process GO:0055082 Cellular chemical homeostasis
Process GO:0055119 Relaxation of cardiac muscle
Process GO:0060047 Heart contraction
Process GO:0060048 Cardiac muscle contraction
Process GO:0060255 Regulation of macromolecule metabolic process
Process GO:0060548 Negative regulation of cell death
Process GO:0060612 Adipose tissue development
Process GO:0061008 Hepaticobiliary system development
Process GO:0061448 Connective tissue development
Process GO:0062197 Cellular response to chemical stress
Process GO:0065007 Biological regulation
Process GO:0065008 Regulation of biological quality
Process GO:0065009 Regulation of molecular function
Process GO:0070252 Actin-mediated cell contraction
Process GO:0070542 Response to fatty acid
Process GO:0070848 Response to growth factor
Process GO:0070887 Cellular response to chemical stimulus
Process GO:0071214 Cellular response to abiotic stimulus
Process GO:0071229 Cellular response to acid chemical
Process GO:0071310 Cellular response to organic substance
Process GO:0071322 Cellular response to carbohydrate stimulus
Process GO:0071326 Cellular response to monosaccharide stimulus
Process GO:0071331 Cellular response to hexose stimulus
Process GO:0071333 Cellular response to glucose stimulus
Process GO:0071363 Cellular response to growth factor stimulus
Process GO:0071462 Cellular response to water stimulus
Process GO:0071464 Cellular response to hydrostatic pressure
Process GO:0071548 Response to dexamethasone
Process GO:0071704 Organic substance metabolic process
Process GO:0071840 Cellular component organization or biogenesis
Process GO:0072359 Circulatory system development
Process GO:0080090 Regulation of primary metabolic process
Process GO:0086003 Cardiac muscle cell contraction
Process GO:0090066 Regulation of anatomical structure size
Process GO:0090075 Relaxation of muscle
Process GO:0090407 Organophosphate biosynthetic process
Process GO:0097009 Energy homeostasis
Process GO:0104004 Cellular response to environmental stimulus
Process GO:0110053 Regulation of actin filament organization
Process GO:0120261 Regulation of heterochromatin organization
Process GO:1901214 Regulation of neuron death
Process GO:1901215 Negative regulation of neuron death
Process GO:1901576 Organic substance biosynthetic process
Process GO:1901654 Response to ketone
Process GO:1901698 Response to nitrogen compound
Process GO:1901700 Response to oxygen-containing compound
Process GO:1901701 Cellular response to oxygen-containing compound
Process GO:1901879 Regulation of protein depolymerization
Process GO:1901880 Negative regulation of protein depolymerization
Process GO:1902275 Regulation of chromatin organization
Process GO:1902531 Regulation of intracellular signal transduction
Process GO:1902533 Positive regulation of intracellular signal transduction
Process GO:1902903 Regulation of supramolecular fiber organization
Process GO:1902904 Negative regulation of supramolecular fiber organization
Process GO:1903544 Response to butyrate
Process GO:2000209 Regulation of anoikis
Process GO:2000269 Regulation of fibroblast apoptotic process
Process GO:2000270 Negative regulation of fibroblast apoptotic process
Process GO:2000653 Regulation of genetic imprinting
Process GO:2000811 Negative regulation of anoikis
Component GO:0005622 Intracellular anatomical structure
Component GO:0005737 Cytoplasm
Component GO:0005829 Cytosol
Component GO:0005886 Plasma membrane
Component GO:0005911 Cell-cell junction
Component GO:0005942 Phosphatidylinositol 3-kinase complex
Component GO:0005943 Phosphatidylinositol 3-kinase complex, class IA
Component GO:0005944 Phosphatidylinositol 3-kinase complex, class IB
Component GO:0014704 Intercalated disc
Component GO:0016020 Membrane
Component GO:0019898 Extrinsic component of membrane
Component GO:0030027 Lamellipodium
Component GO:0030054 Cell junction
Component GO:0031252 Cell leading edge
Component GO:0032991 Protein-containing complex
Component GO:0042995 Cell projection
Component GO:0044291 Cell-cell contact zone
Component GO:0061695 Transferase complex, transferring phosphorus-containing groups
Component GO:0070161 Anchoring junction
Component GO:0071944 Cell periphery
Component GO:0097651 Phosphatidylinositol 3-kinase complex, class I
Component GO:0098796 Membrane protein complex
Component GO:0110165 Cellular anatomical entity
Component GO:0120025 Plasma membrane bounded cell projection
Component GO:1902494 Catalytic complex
Component GO:1990234 Transferase complex
Function GO:0000166 Nucleotide binding
Function GO:0003824 Catalytic activity
Function GO:0004672 Protein kinase activity
Function GO:0004674 Protein serine/threonine kinase activity
Function GO:0005488 Binding
Function GO:0005515 Protein binding
Function GO:0005524 ATP binding
Function GO:0008047 Enzyme activator activity
Function GO:0016301 Kinase activity
Function GO:0016303 1-phosphatidylinositol-3-kinase activity
Function GO:0016307 Phosphatidylinositol phosphate kinase activity
Function GO:0016740 Transferase activity
Function GO:0016772 Transferase activity, transferring phosphorus-containing groups
Function GO:0016773 Phosphotransferase activity, alcohol group as acceptor
Function GO:0017076 Purine nucleotide binding
Function GO:0019207 Kinase regulator activity
Function GO:0019209 Kinase activator activity
Function GO:0019887 Protein kinase regulator activity
Function GO:0030234 Enzyme regulator activity
Function GO:0030295 Protein kinase activator activity
Function GO:0030554 Adenyl nucleotide binding
Function GO:0032553 Ribonucleotide binding
Function GO:0032555 Purine ribonucleotide binding
Function GO:0032559 Adenyl ribonucleotide binding
Function GO:0035004 Phosphatidylinositol 3-kinase activity
Function GO:0035005 1-phosphatidylinositol-4-phosphate 3-kinase activity
Function GO:0035639 Purine ribonucleoside triphosphate binding
Function GO:0036094 Small molecule binding
Function GO:0043167 Ion binding
Function GO:0043168 Anion binding
Function GO:0043560 Insulin receptor substrate binding
Function GO:0046934 phosphatidylinositol-4,5-bisphosphate 3-kinase activity
Function GO:0052742 Phosphatidylinositol kinase activity
Function GO:0052812 phosphatidylinositol-3,4-bisphosphate 5-kinase activity
Function GO:0052813 Phosphatidylinositol bisphosphate kinase activity
Function GO:0097159 Organic cyclic compound binding
Function GO:0097367 Carbohydrate derivative binding
Function GO:0098772 Molecular function regulator activity
Function GO:0106310 Protein serine kinase activity
Function GO:0140096 Catalytic activity, acting on a protein
Function GO:1901265 Nucleoside phosphate binding
Function GO:1901363 Heterocyclic compound binding

Pathway annotation


Category Term ID Term description
RCTM RNO-109582 Hemostasis
RCTM RNO-109704 PI3K Cascade
RCTM RNO-112399 IRS-mediated signalling
RCTM RNO-114604 GPVI-mediated activation cascade
RCTM RNO-1227986 Signaling by ERBB2
RCTM RNO-1236394 Signaling by ERBB4
RCTM RNO-1250342 PI3K events in ERBB4 signaling
RCTM RNO-1257604 PIP3 activates AKT signaling
RCTM RNO-1266738 Developmental Biology
RCTM RNO-1280215 Cytokine Signaling in Immune system
RCTM RNO-1280218 Adaptive Immune System
RCTM RNO-1430728 Metabolism
RCTM RNO-1433557 Signaling by SCF-KIT
RCTM RNO-1483255 PI Metabolism
RCTM RNO-1483257 Phospholipid metabolism
RCTM RNO-162582 Signal Transduction
RCTM RNO-1660499 Synthesis of PIPs at the plasma membrane
RCTM RNO-166520 Signaling by NTRKs
RCTM RNO-168249 Innate Immune System
RCTM RNO-168256 Immune System
RCTM RNO-177929 Signaling by EGFR
RCTM RNO-180292 GAB1 signalosome
RCTM RNO-186763 Downstream signal transduction
RCTM RNO-186797 Signaling by PDGF
RCTM RNO-187037 Signaling by NTRK1 (TRKA)
RCTM RNO-190236 Signaling by FGFR
RCTM RNO-194138 Signaling by VEGF
RCTM RNO-194315 Signaling by Rho GTPases
RCTM RNO-1963642 PI3K events in ERBB2 signaling
RCTM RNO-198203 PI3K/AKT activation
RCTM RNO-199418 Negative regulation of the PI3K/AKT network
RCTM RNO-201556 Signaling by ALK
RCTM RNO-202403 TCR signaling
RCTM RNO-202424 Downstream TCR signaling
RCTM RNO-202733 Cell surface interactions at the vascular wall
RCTM RNO-2029480 Fcgamma receptor (FCGR) dependent phagocytosis
RCTM RNO-2029485 Role of phospholipids in phagocytosis
RCTM RNO-210993 Tie2 Signaling
RCTM RNO-2172127 DAP12 interactions
RCTM RNO-2404192 Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
RCTM RNO-2424491 DAP12 signaling
RCTM RNO-2428924 IGF1R signaling cascade
RCTM RNO-2428928 IRS-related events triggered by IGF1R
RCTM RNO-2454202 Fc epsilon receptor (FCERI) signaling
RCTM RNO-2730905 Role of LAT2/NTAL/LAB on calcium mobilization
RCTM RNO-372790 Signaling by GPCR
RCTM RNO-388396 GPCR downstream signalling
RCTM RNO-388841 Costimulation by the CD28 family
RCTM RNO-389356 CD28 co-stimulation
RCTM RNO-389357 CD28 dependent PI3K/Akt signaling
RCTM RNO-416476 G alpha (q) signalling events
RCTM RNO-422475 Axon guidance
RCTM RNO-4420097 VEGFA-VEGFR2 Pathway
RCTM RNO-449147 Signaling by Interleukins
RCTM RNO-451927 Interleukin-2 family signaling
RCTM RNO-512988 Interleukin-3, Interleukin-5 and GM-CSF signaling
RCTM RNO-556833 Metabolism of lipids
RCTM RNO-5654687 Downstream signaling of activated FGFR1
RCTM RNO-5654689 PI-3K cascade:FGFR1
RCTM RNO-5654695 PI-3K cascade:FGFR2
RCTM RNO-5654696 Downstream signaling of activated FGFR2
RCTM RNO-5654708 Downstream signaling of activated FGFR3
RCTM RNO-5654710 PI-3K cascade:FGFR3
RCTM RNO-5654716 Downstream signaling of activated FGFR4
RCTM RNO-5654720 PI-3K cascade:FGFR4
RCTM RNO-5654736 Signaling by FGFR1
RCTM RNO-5654738 Signaling by FGFR2
RCTM RNO-5654741 Signaling by FGFR3
RCTM RNO-5654743 Signaling by FGFR4
RCTM RNO-5673001 RAF/MAP kinase cascade
RCTM RNO-5683057 MAPK family signaling cascades
RCTM RNO-5684996 MAPK1/MAPK3 signaling
RCTM RNO-6806834 Signaling by MET
RCTM RNO-6811558 PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
RCTM RNO-74751 Insulin receptor signalling cascade
RCTM RNO-74752 Signaling by Insulin receptor
RCTM RNO-76002 Platelet activation, signaling and aggregation
RCTM RNO-8851907 MET activates PI3K/AKT signaling
RCTM RNO-8853659 RET signaling
RCTM RNO-8939211 ESR-mediated signaling
RCTM RNO-9006335 Signaling by Erythropoietin
RCTM RNO-9006925 Intracellular signaling by second messengers
RCTM RNO-9006931 Signaling by Nuclear Receptors
RCTM RNO-9006934 Signaling by Receptor Tyrosine Kinases
RCTM RNO-9009391 Extra-nuclear estrogen signaling
RCTM RNO-9012999 RHO GTPase cycle
RCTM RNO-9013149 RAC1 GTPase cycle
RCTM RNO-9013404 RAC2 GTPase cycle
RCTM RNO-9027276 Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
RCTM RNO-912526 Interleukin receptor SHC signaling
RCTM RNO-912631 Regulation of signaling by CBL
RCTM RNO-9607240 FLT3 Signaling
RCTM RNO-9675108 Nervous system development
RCTM RNO-9716542 Signaling by Rho GTPases, Miro GTPases and RHOBTB3
WikiPathways WP1309 Toll-like receptor signaling pathway
WikiPathways WP188 Focal adhesion
WikiPathways WP1968 Genetic alterations of lung cancer
WikiPathways WP2376 Nuclear factor, erythroid-derived 2, like 2 signaling pathway
WikiPathways WP319 IL-3 signaling pathway
WikiPathways WP351 Regulation of actin cytoskeleton
WikiPathways WP376 Renin-angiotensin system
WikiPathways WP569 IL-2 signaling pathway
WikiPathways WP94 Hepatocyte growth factor receptor signaling
RCTM MAP-109582 Hemostasis
RCTM MAP-109704 PI3K Cascade
RCTM MAP-112399 IRS-mediated signalling
RCTM MAP-114604 GPVI-mediated activation cascade
RCTM MAP-1227986 Signaling by ERBB2
RCTM MAP-1236394 Signaling by ERBB4
RCTM MAP-1250342 PI3K events in ERBB4 signaling
RCTM MAP-1257604 PIP3 activates AKT signaling
RCTM MAP-1266738 Developmental Biology
RCTM MAP-1280215 Cytokine Signaling in Immune system
RCTM MAP-1280218 Adaptive Immune System
RCTM MAP-1430728 Metabolism
RCTM MAP-1433557 Signaling by SCF-KIT
RCTM MAP-1483255 PI Metabolism
RCTM MAP-1483257 Phospholipid metabolism
RCTM MAP-162582 Signal Transduction
RCTM MAP-1660499 Synthesis of PIPs at the plasma membrane
RCTM MAP-166520 Signaling by NTRKs
RCTM MAP-168249 Innate Immune System
RCTM MAP-168256 Immune System
RCTM MAP-177929 Signaling by EGFR
RCTM MAP-180292 GAB1 signalosome
RCTM MAP-186763 Downstream signal transduction
RCTM MAP-186797 Signaling by PDGF
RCTM MAP-187037 Signaling by NTRK1 (TRKA)
RCTM MAP-190236 Signaling by FGFR
RCTM MAP-194138 Signaling by VEGF
RCTM MAP-194315 Signaling by Rho GTPases
RCTM MAP-1963642 PI3K events in ERBB2 signaling
RCTM MAP-198203 PI3K/AKT activation
RCTM MAP-199418 Negative regulation of the PI3K/AKT network
RCTM MAP-201556 Signaling by ALK
RCTM MAP-202403 TCR signaling
RCTM MAP-202424 Downstream TCR signaling
RCTM MAP-202733 Cell surface interactions at the vascular wall
RCTM MAP-2029480 Fcgamma receptor (FCGR) dependent phagocytosis
RCTM MAP-2029485 Role of phospholipids in phagocytosis
RCTM MAP-210993 Tie2 Signaling
RCTM MAP-2172127 DAP12 interactions
RCTM MAP-2404192 Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
RCTM MAP-2424491 DAP12 signaling
RCTM MAP-2428924 IGF1R signaling cascade
RCTM MAP-2428928 IRS-related events triggered by IGF1R
RCTM MAP-2454202 Fc epsilon receptor (FCERI) signaling
RCTM MAP-2730905 Role of LAT2/NTAL/LAB on calcium mobilization
RCTM MAP-372790 Signaling by GPCR
RCTM MAP-388396 GPCR downstream signalling
RCTM MAP-388841 Costimulation by the CD28 family
RCTM MAP-389356 CD28 co-stimulation
RCTM MAP-389357 CD28 dependent PI3K/Akt signaling
RCTM MAP-416476 G alpha (q) signalling events
RCTM MAP-422475 Axon guidance
RCTM MAP-4420097 VEGFA-VEGFR2 Pathway
RCTM MAP-449147 Signaling by Interleukins
RCTM MAP-451927 Interleukin-2 family signaling
RCTM MAP-512988 Interleukin-3, Interleukin-5 and GM-CSF signaling
RCTM MAP-556833 Metabolism of lipids
RCTM MAP-5654687 Downstream signaling of activated FGFR1
RCTM MAP-5654689 PI-3K cascade:FGFR1
RCTM MAP-5654695 PI-3K cascade:FGFR2
RCTM MAP-5654696 Downstream signaling of activated FGFR2
RCTM MAP-5654708 Downstream signaling of activated FGFR3
RCTM MAP-5654710 PI-3K cascade:FGFR3
RCTM MAP-5654716 Downstream signaling of activated FGFR4
RCTM MAP-5654720 PI-3K cascade:FGFR4
RCTM MAP-5654736 Signaling by FGFR1
RCTM MAP-5654738 Signaling by FGFR2
RCTM MAP-5654741 Signaling by FGFR3
RCTM MAP-5654743 Signaling by FGFR4
RCTM MAP-5673001 RAF/MAP kinase cascade
RCTM MAP-5683057 MAPK family signaling cascades
RCTM MAP-5684996 MAPK1/MAPK3 signaling
RCTM MAP-6806834 Signaling by MET
RCTM MAP-6811558 PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
RCTM MAP-74751 Insulin receptor signalling cascade
RCTM MAP-74752 Signaling by Insulin receptor
RCTM MAP-76002 Platelet activation, signaling and aggregation
RCTM MAP-8851907 MET activates PI3K/AKT signaling
RCTM MAP-8853659 RET signaling
RCTM MAP-8939211 ESR-mediated signaling
RCTM MAP-9006335 Signaling by Erythropoietin
RCTM MAP-9006925 Intracellular signaling by second messengers
RCTM MAP-9006931 Signaling by Nuclear Receptors
RCTM MAP-9006934 Signaling by Receptor Tyrosine Kinases
RCTM MAP-9009391 Extra-nuclear estrogen signaling
RCTM MAP-9012999 RHO GTPase cycle
RCTM MAP-9013149 RAC1 GTPase cycle
RCTM MAP-9013404 RAC2 GTPase cycle
RCTM MAP-9027276 Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
RCTM MAP-912526 Interleukin receptor SHC signaling
RCTM MAP-912631 Regulation of signaling by CBL
RCTM MAP-9607240 FLT3 Signaling
RCTM MAP-9675108 Nervous system development
RCTM MAP-9716542 Signaling by Rho GTPases, Miro GTPases and RHOBTB3

Expression profile of Pik3ca in omics data



ID GSE100499
Title Exploring acupuncture mechanism in preconditioning of IRI
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM2685201 MX1 tissue: Myocardium gender: male 7.018797966666667
GSM2685202 MX2 tissue: Myocardium gender: female 6.9410762833333335
GSM2685203 MX3 tissue: Myocardium gender: female 7.444152283333334
GSM2685204 MX4 tissue: Myocardium gender: male 7.258517350000001
GSM2685205 DZ1 tissue: Myocardium gender: male 7.3717190666666665
GSM2685206 DZ2 tissue: Myocardium gender: male 7.4115779999999996
GSM2685207 DZ3 tissue: Myocardium gender: female 7.591714
GSM2685208 DZ4 tissue: Myocardium gender: female 7.394228333333333
GSM2685209 JJ1 tissue: Myocardium gender: male 7.055165266666666
GSM2685210 JJ2 tissue: Myocardium gender: female 7.1040037666666676
GSM2685211 JJ3 tissue: Myocardium gender: female 7.156110300000001
GSM2685212 JJ4 tissue: Myocardium gender: male 6.877048333333334
GSM2685213 NG1 tissue: Myocardium gender: male 6.929257116666666
GSM2685214 NG2 tissue: Myocardium gender: female 7.21718575
GSM2685215 NG3 tissue: Myocardium gender: male 6.8987074
GSM2685216 NG4 tissue: Myocardium gender: female 7.047980083333333
GSM2685217 YL1 tissue: Myocardium gender: male 7.31474545
GSM2685218 YL2 tissue: Myocardium gender: male 7.310299883333333
GSM2685219 YL3 tissue: Myocardium gender: female 7.546162366666667
GSM2685220 YL4 tissue: Myocardium gender: female 7.160188683333334
GSM2685221 QC1 tissue: Myocardium gender: male 6.576857916666666
GSM2685222 QC2 tissue: Myocardium gender: male 6.662290250000001
GSM2685223 QC3 tissue: Myocardium gender: female 6.8017447833333335
GSM2685224 QC4 tissue: Myocardium gender: female 6.596560983333333

ID GSE136833
Title Effects of lidocaine on the expression of rat spinal cord
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4058984 Control_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.304304075499999
GSM4058985 Control_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.3458861365
GSM4058986 Control_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.3415358685
GSM4058987 Lidocaine_1 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.317789925
GSM4058988 Lidocaine_2 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.2172123905
GSM4058989 Lidocaine_3 strain: Sprague-Dawley tissue: Lumbar segment of spinal cord 6.199377237

ID GSE138454
Title Impact of inflammation on hepatic subcellular energetics in anesthetized rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4108997 Sample 1 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1829.0
GSM4108998 Sample 2 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1681.0
GSM4108999 Sample 3 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2485.0
GSM4109000 Sample 4 Isoflurane sepsis anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 2585.0
GSM4109001 Sample 5 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 935.0
GSM4109002 Sample 6 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 929.0
GSM4109003 Sample 7 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 688.0
GSM4109004 Sample 8 Isoflurane control anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 2239.0
GSM4109005 Sample9 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 995.0
GSM4109006 Sample10 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1714.0
GSM4109007 Sample11 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 900.0
GSM4109008 Sample12 Propofol sepsis anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male 1587.0
GSM4109009 Sample13 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 419.0
GSM4109010 Sample14 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 444.0
GSM4109011 Sample 15 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 462.0
GSM4109012 Sample16 Propofol control anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male 498.0

ID GSE139220
Title Expression data from sevoflurane anesthesia treated rat
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4134285 Brain_Control_rep1 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.983003500000001
GSM4134286 Brain_Control_rep2 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.876443500000001
GSM4134287 Brain_Control_rep3 strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus 7.9631425
GSM4134288 Brain_Sevoflurane_rep1 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 7.661376
GSM4134289 Brain_Sevoflurane_rep2 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 8.0416385
GSM4134290 Brain_Sevoflurane_rep3 strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus 8.075920499999999

ID GSE143895
Title GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4276356 dhsc01 strain: Sprague Dawley tissue: DHSC treatment: CCI 31.02
GSM4276357 dhsc03 strain: Sprague Dawley tissue: DHSC treatment: CCI 31.615
GSM4276358 dhsc05 strain: Sprague Dawley tissue: DHSC treatment: CCI 33.441
GSM4276359 dhsc13 strain: Sprague Dawley tissue: DHSC treatment: SHAM 32.652
GSM4276360 dhsc15 strain: Sprague Dawley tissue: DHSC treatment: SHAM 27.654

ID GSE157924
Title Regulation of acupuncture on genes in brain stem
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM4780973 Rattus_JSSZ(Sham) tissue: Rattus brainstem of modeling treatment: Sham 11.16327033
GSM4780974 Rattus_JXZ(Hand Acu) tissue: Rattus brainstem of modeling treatment: Hand Acu 11.13979006
GSM4780975 Rattus_MXZ(TBI) tissue: Rattus brainstem of modeling treatment: TBI 11.15462595

ID GSE1779
Title Effect of Isoflurane and LTM on basolateral amygdala
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM30790 baseline control 01 male, 275-300g 292.6
GSM30791 baseline control 02 male, 275-300g 402.6
GSM30792 baseline control 03 male, 275-300g 230.1
GSM30793 baseline control 04 male, 275-300g 212.5
GSM30794 baseline control 05 male, 275-300g 342.3
GSM30795 baseline control 06 male, 275-300g 335.8
GSM30796 baseline control 07 male, 275-300g 323.8
GSM30797 baseline control 08 male, 275-300g 241.0
GSM30798 baseline control 09 male, 275-300g 239.7
GSM30799 pain 01 253.0
GSM30800 pain 02 297.3
GSM30801 pain 03 336.4
GSM30802 pain 04 280.3
GSM30803 pain 05 260.8
GSM30804 FC 01 239.8
GSM30805 FC 02 342.7
GSM30806 FC 03 320.0
GSM30807 FC 04 260.7
GSM30808 FC 05 364.9
GSM30809 IFC 01 420.8
GSM30810 IFC 02 308.9
GSM30811 IFC 03 365.2
GSM30812 IFC 04 269.3
GSM30813 IFC 05 182.2
GSM99800 isoflurane 01 male, 275-300g 346.4
GSM99801 isoflurane 02 male, 275-300g 368.2
GSM99802 isoflurane 03 male, 275-300g 362.6
GSM99803 isoflurane 04 male, 275-300g 389.8
GSM99804 isoflurane 05 male, 275-300g 218.0

ID GSE190472
Title Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5724271 model 21 Sex: female tissue: Uterine tissue condition: model 308.7072
GSM5724272 model 22 Sex: female tissue: Uterine tissue condition: model 286.2549
GSM5724273 model 23 Sex: female tissue: Uterine tissue condition: model 264.0774
GSM5724274 treatment31 Sex: female tissue: Uterine tissue condition: treatment 240.3185
GSM5724275 treatment32 Sex: female tissue: Uterine tissue condition: treatment 218.1992
GSM5724276 treatment33 Sex: female tissue: Uterine tissue condition: treatment 258.9492
GSM5724277 control 41 Sex: female tissue: Uterine tissue condition: control 205.5481
GSM5724278 control 42 Sex: female tissue: Uterine tissue condition: control 249.1992
GSM5724279 control 43 Sex: female tissue: Uterine tissue condition: control 291.4798

ID GSE192399
Title Gene expression of brain regions activated by sevoflurane and propofol
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM5746332 LHb, Sevoflurane, 60mins brain region: the lateral habenula (LHb) treatment: Sevoflurane 11.14
GSM5746333 LHb, O2, 60mins brain region: the lateral habenula (LHb) treatment: O2 11.2394
GSM5746334 MHb, Sevoflurane, 60mins brain region: the medial habenula (MHb) treatment: Sevoflurane 11.8735
GSM5746335 MHb, O2, 60mins brain region: the medial habenula (MHb) treatment: O2 11.9298
GSM5746336 Sol, Sevoflurane, 60mins brain region: the solitary nucleus (Sol) treatment: Sevoflurane 10.4365
GSM5746337 Sol, O2, 60mins brain region: the solitary nucleus (Sol) treatment: O2 10.8434
GSM5746338 Mve, Sevoflurane, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane 10.8781
GSM5746339 Mve, O2, 60mins brain region: the medial vestibular nucleus (MVe) treatment: O2 10.4922
GSM5746340 LHb, Propofol, 60mins brain region: the lateral habenula (LHb) treatment: Propofol 10.6713
GSM5746341 LHb, Intralipos, 60mins brain region: the lateral habenula (LHb) treatment: Intralipos 10.8573
GSM5746342 MHb, Propofol, 60mins brain region: the medial habenula (MHb) treatment: Propofol 11.3037
GSM5746343 MHb, Intralipos, 60mins brain region: the medial habenula (MHb) treatment: Intralipos 11.6545
GSM5746344 Sol, Propofol, 60mins brain region: the solitary nucleus (Sol) treatment: Propofol 10.3912
GSM5746345 Sol, Intralipos, 60mins brain region: the solitary nucleus (Sol) treatment: Intralipos 10.4124
GSM5746346 MVe, Propofol, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Propofol 10.8316
GSM5746347 MVe, Intralipos, 60mins brain region: the medial vestibular nucleus (MVe) treatment: Intralipos 10.5447

ID GSE205202
Title Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat]
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM6208507 Rat_Baseline_0h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.262223
GSM6208508 Rat_Baseline_0h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.02438
GSM6208509 Rat_Baseline_0h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.158467
GSM6208510 Rat_Baseline_0h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.319269
GSM6208511 Rat_Baseline_0h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 8.119661
GSM6208512 Rat_Vehicle_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.122519
GSM6208513 Rat_Vehicle_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.029489
GSM6208514 Rat_Vehicle_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.03224
GSM6208515 Rat_Vehicle_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.07276
GSM6208516 Rat_Vehicle_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 8.130278
GSM6208517 Rat_Vehicle_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.989718
GSM6208518 Rat_Vehicle_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.819927
GSM6208519 Rat_Vehicle_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.938408
GSM6208520 Rat_Vehicle_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.908464
GSM6208521 Rat_Vehicle_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 7.898828
GSM6208522 Rat_Vehicle_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.096608
GSM6208523 Rat_Vehicle_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.239593
GSM6208524 Rat_Vehicle_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.045081
GSM6208525 Rat_Vehicle_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.316768
GSM6208526 Rat_Vehicle_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 8.144943
GSM6208527 Rat_Vehicle_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.325159
GSM6208528 Rat_Vehicle_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.938521
GSM6208529 Rat_Vehicle_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.009509
GSM6208530 Rat_Vehicle_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 8.004508
GSM6208531 Rat_Vehicle_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 7.995856
GSM6208532 Rat_APAP_03h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.978011
GSM6208533 Rat_APAP_03h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.940713
GSM6208534 Rat_APAP_03h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.931788
GSM6208535 Rat_APAP_03h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 7.950652
GSM6208536 Rat_APAP_03h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 8.067863
GSM6208537 Rat_APAP_06h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.451463
GSM6208538 Rat_APAP_06h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.340179
GSM6208539 Rat_APAP_06h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 7.896245
GSM6208540 Rat_APAP_06h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.367203
GSM6208541 Rat_APAP_06h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 8.220935
GSM6208542 Rat_APAP_09h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.499054
GSM6208543 Rat_APAP_09h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.31384
GSM6208544 Rat_APAP_09h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.200322
GSM6208545 Rat_APAP_09h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.387396
GSM6208546 Rat_APAP_09h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 8.427511
GSM6208547 Rat_APAP_24h_1 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.657387
GSM6208548 Rat_APAP_24h_2 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.632188
GSM6208549 Rat_APAP_24h_3 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 8.376282
GSM6208550 Rat_APAP_24h_4 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.726247
GSM6208551 Rat_APAP_24h_5 tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 7.725204

ID GSE232804
Title EGR3 regulates opioid-related nociception and motivation in male rats
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7383519 ww01_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 1185.0
GSM7383520 ww02_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1247.0
GSM7383521 ww03_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 1179.0
GSM7383522 ww05_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1189.0
GSM7383523 ww06_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 1162.0
GSM7383524 ww07_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1181.0
GSM7383525 ww08_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Salin 1255.0
GSM7383526 ww10_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1124.0
GSM7383527 ww12_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 952.0
GSM7383528 ww13_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1644.0
GSM7383529 ww14_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1083.0
GSM7383530 ww15_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1318.0
GSM7383531 ww16_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1196.0
GSM7383532 ww17_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1512.0
GSM7383533 ww18_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1527.0
GSM7383534 ww20_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 890.0
GSM7383535 ww21_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1324.0
GSM7383536 ww22_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1079.0
GSM7383537 ww23_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 940.0
GSM7383538 ww24_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 942.0
GSM7383539 ww26_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1140.0
GSM7383540 ww27_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1781.0
GSM7383541 ww28_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1384.0
GSM7383542 ww30_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1332.0
GSM7383543 ww31_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1256.0
GSM7383544 ww32_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1023.0
GSM7383545 ww34_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1418.0
GSM7383546 ww35_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1187.0
GSM7383547 ww36_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1532.0
GSM7383548 ww37_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1613.0
GSM7383549 ww38_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1413.0
GSM7383550 www09_Saline_Saline tissue: Brain / mPFC pain: Saline drug: Saline 1678.0
GSM7383551 www19_Saline_OXY tissue: Brain / mPFC pain: Saline drug: OXY 1451.0
GSM7383552 www29_CFA_Saline tissue: Brain / mPFC pain: CFA drug: Saline 1176.0
GSM7383553 www33_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 1399.0
GSM7383554 www39_CFA_OXY tissue: Brain / mPFC pain: CFA drug: OXY 886.0

ID GSE244436
Title Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM7816143 Liver, Control for SevoAnes tissue: liver genotype: wild type treatment: Control for SevoAnes 11.320718
GSM7816144 Liver, Anesthetized with sevoflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h 12.359385
GSM7816145 Liver, Control for DesAnes tissue: liver genotype: wild type treatment: Control for DesAnes 12.027921
GSM7816146 Liver, Anesthetized with desflurane for 6 h tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h 13.529129

ID GSE2982
Title Effect of inhaled anesthetic to cultured cortical neurons
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM61779 Cell Culture Exposure (control1) Cy3 label;Cy5; 0.03683333333333333
GSM61796 Cell Culture Exposure (control2) Cy3; Cy5 0.0469
GSM61797 Cell Culture Exposure (control3) Cy3; Cy5 0.06573333333333332
GSM61798 Cell Culture Exposure (1MAC Halo1) Cy3; Cy5 0.01466666666666668
GSM61799 Cell Culture Exposure (1MAC Halo2) Cy3; Cy5 0.10519666666666666
GSM61800 Cell Culture Exposure (1MAC Halo3) Cy3; Cy5 0.0575
GSM61801 Cell Culture Exposure (3MAC Halo1) Cy3; Cy5 0.042600000000000006
GSM61802 Cell Culture Exposure (3MAC Halo2) Cy3; Cy5 0.0499
GSM61803 Cell Culture Exposure (3MAC Halo3) Cy3; Cy5 0.056633333333333334
GSM61804 Cell Culture Exposure (3MAC ISO1) Cy3; Cy5 0.0599
GSM61805 Cell Culture Exposure (3MAC ISO2) Cy3; Cy5 0.013466666666666668
GSM61806 Cell Culture Exposure (3MAC ISO3) Cy3; Cy5 0.017100000000000004

ID GSE48025
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 8.786676349
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 8.749295003
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.67415047
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.7201093
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.869570307
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.205469648
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 7.819223969
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 8.520194806
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 8.590921836
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 8.749893511
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 7.934530837
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.257489861
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 7.946309746
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 7.807196787
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 7.999212136
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 7.874061961
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 7.754418707
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 7.837134661
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 7.919437085
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 8.07222435
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.265155448
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.710437204
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 7.988696388
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 8.185860445

ID GSE58456
Title Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2)
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1515.979424
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1152.105623
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 986.3630575
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 1424.852157
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 1429.789691
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1173.20423
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1324.814476
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1238.314514
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1325.598345
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1119.002282
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1169.846655
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1436.145144
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 823.7532219
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1250.399381

ID GSE58460
Title Rheumatoid Arthritis Rat Model Treated with Acupuncture
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM1165929 RAT_NORA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 8.786676349
GSM1165930 RAT_NORA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy 8.749295003
GSM1165931 RAT_RA_T0_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.67415047
GSM1165932 RAT_RA_T0_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy 8.7201093
GSM1165933 RAT_NORA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.869570307
GSM1165934 RAT_NORA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy 8.205469648
GSM1165935 RAT_AP_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 7.819223969
GSM1165936 RAT_AP_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy 8.520194806
GSM1165937 RAT_MTX_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 8.590921836
GSM1165938 RAT_MTX_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy 8.749893511
GSM1165939 RAT_ANE_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 7.934530837
GSM1165940 RAT_ANE_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy 8.257489861
GSM1165941 RAT_PLA_1h_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 7.946309746
GSM1165942 RAT_PLA_1h_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy 7.807196787
GSM1165943 RAT_NORA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 7.999212136
GSM1165944 RAT_NORA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy 7.874061961
GSM1165945 RAT_AP_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 7.754418707
GSM1165946 RAT_AP_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy 7.837134661
GSM1165947 RAT_MTX_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 7.919437085
GSM1165948 RAT_MTX_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy 8.07222435
GSM1165949 RAT_ANE_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.265155448
GSM1165950 RAT_ANE_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy 8.710437204
GSM1165951 RAT_PLA_34d_1 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 7.988696388
GSM1165952 RAT_PLA_34d_2 gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy 8.185860445
GSM1412003 RAT_NORA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412004 RAT_NORA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412005 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412006 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412007 RAT_NORA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412008 RAT_NORA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412009 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412010 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412011 RAT_MTX_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412012 RAT_MTX_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412013 RAT_ANE_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412014 RAT_ANE_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412015 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412016 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412017 RAT_NORA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412018 RAT_NORA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412019 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412020 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412021 RAT_MTX_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412022 RAT_MTX_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412023 RAT_ANE_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412024 RAT_ANE_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412025 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412026 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells
GSM1412027 RAT_RA_T0_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412028 RAT_RA_T0_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412029 RAT_AP_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412030 RAT_AP_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412031 RAT_PLA_1h_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412032 RAT_PLA_1h_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412033 RAT_AP_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412034 RAT_AP_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412035 RAT_PLA_34d_1 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1412036 RAT_PLA_34d_2 strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue
GSM1693996 Peripheral blood mononuclear cells from NORA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap 1515.979424
GSM1693997 Peripheral blood mononuclear cells from NORA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 1152.105623
GSM1693998 Peripheral blood mononuclear cells from NORA before therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy 986.3630575
GSM1693999 Peripheral blood mononuclear cells from RA before therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 1424.852157
GSM1694000 Peripheral blood mononuclear cells from RA before therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy 1429.789691
GSM1694001 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1173.20423
GSM1694002 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap 1324.814476
GSM1694003 Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy 1238.314514
GSM1694004 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1325.598345
GSM1694005 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1119.002282
GSM1694006 Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy 1169.846655
GSM1694007 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1436.145144
GSM1694008 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 823.7532219
GSM1694009 Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy 1250.399381

ID GSE8911
Title Skeletal muscle after fine needle stimulation
Organism Rattus norvegicus
GSM Sample info Characteristics Value
GSM225891 Skeletal muscle sample from fine needle-stimulated hindlimb Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb 215.179
GSM225892 Skeletal muscle sample from control hindlimb Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb 231.525